M&A Deal Summary

Asensus Acquires TELELAP ALF-X

On September 21, 2015, Asensus acquired information technology company TELELAP ALF-X from Sofar for 25M USD

Acquisition Highlights
  • This is Asensus’ 1st transaction in the Information Technology sector.
  • This is Asensus’ 2nd largest (disclosed) transaction.
  • This is Asensus’ 1st transaction in Italy.

M&A Deal Summary

Date 2015-09-21
Target TELELAP ALF-X
Sector Information Technology
Buyer(s) Asensus
Sellers(s) Sofar
Deal Type Divestiture
Deal Value 25M USD

Target

TELELAP ALF-X

Italy
TELELAP ALF-X is a robotic surgical system provides an advantages of robotic surgery to patients while enabling surgeons with innovative new technology such as eye tracking and haptics.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Asensus

Durham, North Carolina, United States

Category Company
Founded 2006
Sector Medical Products
Employees207
Revenue 9M USD (2023)
DESCRIPTION

Asensus is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options. Asensus was founded in 2006 and is based in Durham, North Carolina.


DEAL STATS #
Overall 2 of 3
Sector: Information Technology M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Italy M&A 1 of 1
Year: 2015 M&A 1 of 1
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-09-04 SafeStitch Medical

Miami, Florida, United States

SafeStitch Medical, Inc., a developmental stage medical device company, engages in the development of medical devices in the United States.

Buy $170M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-09-23 MST Medical Surgery Technologies

Yokneam, Israel

MST Medical Surgery Technologies Ltd. is a medical technology company focused on developing software-based image analytics platform powered by advanced visualization, scene recognition, artificial intelligence, machine learning and data analytics. MST was formed in 2005 and is based in Yokneam, Israel.

Buy -

Seller(S) 1

SELLER

Sofar

Trezzano Rosa, Italy

Category Company
Founded 1968
Sector Life Science
Revenue 113M EUR (2021)
DESCRIPTION

Sofar is an Italian pharmaceutical company active in the research, production, and marketing of drugs, medical devices, and dietary supplements -with a long-standing tradition and well-known to professionals and patients. Sofar was formed in 1968 and is based in Trezzano Rosa, Italy.


DEAL STATS #
Overall 1 of 1
Sector: Information Technology M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Italy M&A 1 of 1
Year: 2015 M&A 1 of 1
Size (of disclosed) 1 of 1